Lipid mediators in innate immunity against tuberculosis: Opposing roles of PGE 2 and LXA 4 in the induction of macrophage death

Journal of Experimental Medicine

Volumn 205, Issue 12, 2008, Pages 2791-2801

  Chen, Minjian ^a   Divangahi, Maziar ^a   Gan, Huixian ^a   Shin, Daniel S J ^a   Hong, Song ^b   Lee, David M ^a   Serhan, Charles N ^b   Behar, Samuel M ^a   Remold, Heinz G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC ADENOSINE DIPHOSPHATE RIBOSE; CYCLIC AMP DEPENDENT PROTEIN KINASE; PROSTAGLANDIN E SYNTHASE; PROSTANOID; ISOMERASE; LIPOXIN; LIPOXIN A; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN EP2 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; CELL DEATH; ENZYME ACTIVATION; INNATE IMMUNITY; MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; VIRUS REPLICATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; GENETICS; HUMAN; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; MITOCHONDRION; MOUSE MUTANT; PATHOGENICITY; PHYSIOLOGY; ULTRASTRUCTURE;

ANIMALS; CELL DEATH; CELLS, CULTURED; DINOPROSTONE; HUMANS; IMMUNITY, INNATE; INTRAMOLECULAR OXIDOREDUCTASES; LIPOXINS; LUNG; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA; MOLECULAR STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, PROSTAGLANDIN E; TUBERCULOSIS;

EID: 58149296186     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20080767     Document Type: Article

References (63)

1. Corbett, E.L., C.J. Watt, N. Walker, B.G. Williams, M.C. Raviglione, and C. Dye. 2003. The growing burden of tuberculosis: global trends, and interactions with the HIV epidemic. Arch. Intern. Med. 163: 1009-1021.
2. Dannenberg, A.M., and G.A. Rook. 1994. Pathogenesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage-activating immune responses- dual mechanisms that control bacillary multiplication. In Tuberculosis. Pathogenesis, Protection and Control. Bloom B R, editor. American Society for Microbiology, Washington DC. 459-484.
3. Leemans, J.C., N.P. Juffermans, S. Florquin, N. van Rooijen, M.J. Verwordeldonk, A. Verbon, S.J.H. van Deventer, T. van der Poll. 2001. Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J. Immunol. 166:4604-4611.
4. Russell, D.G., H.C. Mwandumba, and E.E. Rhoades. 2002. Mycobacterium and the coat of many lipids. J. Cell Biol. 158:421-426.
5. Sturgill-Koszycki, S., U.E. Schaible, and D.G. Russell. 1996. Mycobacterium-containing phagosomes are accessible to early endo- somes and reflect a transitional state in normal phagosome biogenesis. EMBOJ. 15:6960-6968.
6. Keane, J., M.K. Balcewicz-Sablinska, H.G. Remold, G.L. Chupp, B.B. Meek, M.J. Fenton, and H. Kornfeld. 1997. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 65:298-304.
7. Park, J.S., M.H. Tamayo, M. Gonzales-Juarrero, I.M. Orme, and D.J. Ordway. 2006. Virulent clinical isolates of Mycobacterium tuberculosis grow rapidly and induce cellular necrosis but minimal apoptosis in mu- rine macrophages. J. Leukoc. Biol. 79:80-86.
8. Chen, M., H. Gan, and H.G. Remold. 2006. A mechanism of virulence: virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J. Immunol. 176:3707-3716.
9. Kroemer, G., B. Dallaporta, and M. Resche-Rigon. 1998. The mito- chondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60:619-642.
10. Deshmukh, M., K. Kuida, and E.M. Johnson. 2000. Caspase inhibition extends the commitment to neuronal death beyond cytochrome c release to the point of mitochondrial depolarization. J. Cell Biol. 150:131-143.
11. Duvall, E., and A.H. Wyllie. 1986. Death and the cell. Immunol. Today. 7:115-119.
12. Keane, J., H.G. Remold, and H. Kornfeld. 2000. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J. Immunol. 164:2016-2020.
13. Braunstein, M., B.J. Espinose, J. Chan, J.T. Belisle, and W.R. Jacobs. 2003. SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis. Mol. Microbiol. 48:453-464.
14. Schaible, U.E., F. Winau, P. Sieling, K. Fischer, H.L. Collins, K. Hagens, R.L. Modlin, V. Brinkmann, and S.H. Kaufmann. 2003. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat. Med. 9:1039-1046.
15. Fratazzi, C., R.D. Arbeit, C. Carini, and H.G. Remold. 1997. Programmed cell death of Mycobacterium avium serovar 4- infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J. Immunol. 158:4320-4327.
16. Molloy, A., P. Laochumroonvorapong, and G. Kaplan. 1994. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intra- cellular bacillus Calmette-Guérin. J. Exp. Med. 180:1499-1509.
17. Lee, J., H.G. Remold, M.H. Ieung, and H.K. Kornfeld. 2006. Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J. Immunol. 176:4267-4274.
18. Sly, L.M., S.M. Hingley-Wilson, N.E. Reiner, and W.R. McMaster. 2003. Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1. J. Immunol. 170:430-437.
19. Green, D.R., and G. Kroemer. 2004. The pathophysiology of mito- chondrial cell death. Science. 305:626-629.
20. Budd, R.C. 2001. Activation-induced cell death. Curr. Opin. Immunol. 13:356-362.
21. Vaux, D.L., and A. Strasser. 1996. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA. 93:2239-2244.
22. Thornberry, N.A., and Y. Lazebnik. 1998. Caspases: enemies within. Science. 281:1312-1316.
23. Rizzuto, R., P. Pinton, D. Ferrari, M. Chami, G. Szabadhai, P.J. Magalhaes, F. DiVirgilio, and T. Pozzan. 2003. Calcium and apoptosis: facts and hypotheses. Oncogene. 22:8619-8627.
24. Green, D.R. 2005. Apoptotic pathways: ten minutes to dead. Cell. 121:671-674.
25. Frigui, W., D. Bottal, L. Majlessi, M. Monot, E. Josselin, P. Bridin, T. Garnier, B. Gicquel, C. Martin, C. Leclerc, S. T. Cole, and R. Brosch. 2008. Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by Phop. PLoS Pathog. 4:e33.
26. Gan, H., X. He, L. Duan, E. Mirabile-Levens, H. Kornfeld, and H.G. Remold. 2005. Enhancement of antimycobacterial activity of macro-phages by stabilization of inner mitochondrial membrane potential. J. Infect. Dis. 191:1292-1300.
27. Duan, L., H. Gan, J. Arm, and H.G. Remold. 2001. Cytosolic phos- pholipase A2 participates with TNF-alpha in the induction of apoptosis of human macrophages infected with Mycobacterium tuberculosis H37Ra. J. Immunol. 166:7469-7476.
28. Kudo, I., and M. Murakami. 2002. Phosphatase A2 enzymes. Prostaglandins Other Lipid Mediat. 68-69:3-58.
29. Wu, Y.L., X.R. Jiang, A.C. Newland, and S.M. Kelsey. 1998. Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells. J. Immunol. 160:5929-5936.
30. Wissing, D., H. Mouritzen, M. Egeblad, G.G. Poirier, and M. Jaattela. 1997. Involvement of caspase-dependent activation of cytosolic phos- pholipase A2 in tumor necrosis factor-induced apoptosis. Proc. Natl. Acad. Sci. USA. 94:5073-5077.
31. Serhan, C.N. 1997. Lipoxins and novel aspirin-triggered 15-epi-lipox- ins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins. 53:107-137.
32. Godson, C., S. Mitchell, K. Harvey, N.A. Petasis, N. Hogg, and H.R. Brady. 2000. Lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 164:1663-1667.
33. Borgeat, P., and P.H. Naccache. 1990. Biosynthesis and biological activity of leukotriene B4. Clin. Biochem. 23:459-468.
34. Rocca, B., and G.A. FitzGerald. 2002. Cyclooxygenases and prostaglan- dins: shaping up the immune response. Int. Immunopharmacol. 2:603-630.
35. Murakami, M., H. Naraba, T. Tanioka, N. Semmyo, Y. Nakatani, F. Kojima, T. Ikeda, M. Fueki, A. Ueno, S. Oh-Ishi, and I. Kudo. 2000. Regulation of prostaglandin E2 biosynthesis by inducible membrane- associated prostaglandin E2 synthase that acts in concert with cyclooxy- genase-2. J. Biol. Chem. 275:32783-32792.
36. Tilley, S.L., T.M. Coffman, and B.H. Coller. 2001. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108:15-23.
37. Zamora, R., H. Bult, and A.G. Herman. 1998. The role of prostaglan- din E2 and nitric oxide in cell death in J774 murine macrophages. Eur. J. Pharmacol. 349:307-315.
38. Bafica, A., C.A. Scanga, C. Serhan, F. Machado, S. White, A. Sher, and A. Aliberti. 2005. Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. J. Clin. Invest. 115:1601-1606.
39. Levy, B.D., G.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan. 2001. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2:612-619.
40. Claria, J. 2003. Cycolooxygenase-2 biology. Curr. Pharm. Des. 9:2177-2190.
41. Zamzami, N., P. Marchetti, M. Castedo, C. Zanin, J.L. Vayssiere, P.X. Petit, and G. Kroemer. 1995. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181:1661-1672.
42. Trebino, C.E., J.L. Stock, C.P. Gibbons, B.M. Naiman, T.S. Wachtmann, J.P. Umland, K. Pandher, J.-M. Lapoite, S. Saha, M.L. Roach, et al. 2003. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc. Natl. Acad. Sci. USA. 100:9044-9049.
43. Nataraj, C., D.W. Thomas, S.L. Tilley, M.T. Nguyen, R. Mannon, B.H. Koller, and T.M. Coffman. 2001. Receptors for prostaglandin E (2) that regulate cellular immune responses in the mouse. J. Clin. Invest. 108:1229-1235.
44. Stock, J.L., K. Shinjo, J. Burkhardt, M. Roach, K. Taniguchi, T. Ishikawa, H.-S. Kim, P.J. Flannery, T.M. Coffman, J.D. McNeish, and L.P. Audoly. 2001. The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure. J. Clin. Invest. 107:325-331.
45. Tilley, S.L., L.P. Audoly, E.H. Hicks, H.-S. Kim, P. Flannery, T.M. Coffman, and B.H. Koller. 1999. Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor. J. Clin. Invest. 103:1539-1545.
46. Fleming, E.F., K. Athirakul, M.I. Oliverio, M. Key, J. Goulet, B.H. Koller, and T.M. Coffman. 1998. Urinary concentrating function in mice lacking EP3 receptors for prostaglandin E2. Am. J. Physiol. 275:F955-F961.
47. 4 triggers remodeling of the cardiovascular system at birth. Nature. 390:78-81.
48. Sugimoto, Y., and S. Narumyia. 2007. Prostaglandin E receptors. J. Biol. Chem. 282:11613-11617.
49. Fujino, H., K.A. West, and J.W. Regan. 2002. Phosphorylation of gly-cogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J. Biol. Chem. 277:2614-2619.
50. Zha, J., H. Harada, E. Yang, J. Jockel, and S.J. Korsmeyer. 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell. 87:619-628.
51. Datta, S.R., A. Katsov, L. Hu, A. Petros, S.W. Fesik, M.B. Yaffe, and M.E. Greenbert. 2000. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol. Cell. 6:41-51.
52. Fujino, H., W. Xu, and J.W. Regan. 2003. Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases. J. Biol. Chem. 278:12151-12156.
53. Simpson, C.S., and B.J. Morris. 1995. Induction of c-fos and zif/268 gene expression in rat striatal neurons, following stimulation of D1- like dopamin receptors, involves protein kinase A and protein kinase C. Neuroscience. 68:97-106.
54. Vlahos, C.J., W.F. Matter, R.Y. Hui, and R.F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl- 4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241-5248.
55. Chiang, N., I.M. Fierro, K. Gronert, and C.N. Serhan. 2000. Activation of lipoxin A4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J. Exp. Med. 191:1197-1208.
56. Ariel, A., and C.N. Serhan. 2007. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 28:176-183.
57. Houchen, C.W., M.A. Sturmoski, S. Anant, R.M. Breyer, and W. Stenson. 2002. Prosurvival and antiapoptotic effects of PGE2 in radiation injury are mediated by EP2 receptor in intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 284:G490-G498.
58. 2 dependent cell survival through the PI3 kinase/ AKT pathway. Prostaglandins Other Lipid Mediat. 83:112-120.
59. Chen, W., Y.L. Yu, S.F. Lee, Y.J. Chiang, J.R. Chao, J.H. Huang, C.H. Chiong, J. Huang, M.Z. Lai, J.F. Yang-Yen, and J.J. Yen. 2001. CREB is one component of the binding complex of the Ces-2/E2A- HLF binding element and is an integral part of the interleukin-3 survival signal. Mol. Cell. Biol. 21:4636-4646.
60. Medzhitov, R., and C.A. Janeway Jr. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 91:295-298.
61. Fadok, V.A., D.L. Bratton, and P.M. Henson. 2001. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J. Clin. Invest. 108:957-962.
62. Lu, Y., S. Hong, E. Tjonahen, and C.N. Serhan. 2005. Mediator- lipidomics: databases and search algorithms for PUFA-derived mediators. J. Lipid Res. 46:790-802.
63. Elbashir, S.M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:494-496.